Use of Intravenous Tranexamic Acid During Myomectomy

Summary

The purpose of this study is to determine the effect of the early administration of intravenous (IV) Tranexamic acid (TA) on perioperative bleeding (as defined by measured intraoperative estimated blood loss (EBL), change in pre and post-operative hemoglobin (Hb), and frequency of blood transfusions) in women undergoing a myomectomy.

Timeline

Start

2015-03

Primary completion

2018-02-22

Completion

2018-02-22

Drugs

Indications